Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes

Figure 4

Correlation between the risk model and clinical characteristics. Stratification analysis for the risk model in (a) age ≤65, (b) age >65, (c) female, (d) male, (e) G1 + G2, (f) G3 + G4, (g) stage I + II, (h) stage III + IV, (i) T1, (j) T2+3 + 4, (k) M0, (l) M1, (m) N0, and (n) N1 in TCGA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)